17383 SUNSET AVENUE, PACIFIC PALISADES, CA
Earnings Release
Shareholder votes
Reports First Quarter 2025 Financial Results and Recent Highlights
Annual Report to Security Holders
Amended material disclosure
News
Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
Announces Closing of $100 Million PIPE Financing
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership